用肉毒毒素治疗眼线:你的病人需要稳定地眉吗?
Aesthetic surgery journal
|November 28, 2023
概括
在注射肉毒素注射时持续眉对皮线的注射位置的距离有很小的差异. 眉可能只适用于40岁以上的患者,以避免潜在的副作用.
科学领域:
- 化品皮肤科 化品皮肤科
- 神经调节是一种神经调节.
- 面部解剖学 面部解剖学
背景情况:
- 玻尿酸毒素注射可引起由于可变的肌肉关系的副作用.
- 一个常见的建议是在治疗期间保持稳定的眉,以潜在地提高疗效和降低风险.
研究的目的:
- 为了调查,在持续眉和休息的患者之间,波纹剂注射部位和中线之间的数字口径评估距离是否有显著差异.
- 为了评估眉对注射肉毒素注射部位位置的影响.
主要方法:
- 分析了76名用肉毒素治疗白皮纹的患者的回顾性数据.
- 使用数字标尺测量了注射部位的位置,比较了在手术期间眉和休息的患者.
主要成果:
- 注射点和中线之间的平均距离差异在临床上是微不足道的.
- 然而,放松部位和收缩部位之间的距离在很大一部分患者中超过1.8毫米 (中间部位) 和2.5毫米 (侧部位).
- 在40岁以上的患者中,仅在侧面注射时才观察到统计学意义上的差异.
结论:
- 从注射点到中线的平均距离显示,眉和休息患者之间的差异很小.
- 持续眉可能主要对40岁以上的患者有益.
- 面部不对称性可能是注射部位选择中的混因素.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
488
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
488
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
684
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
684
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
431
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
431


